SMAD4 Tailored Neoadjuvant Therapy for the Treatment of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma, SMART-PANC Trial
Clinical trial NCT07748611 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07748611
- Sponsor
- Northwestern University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2027-02-03
- Primary completion
- 2030-02-03
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.